PAVmed Inc.
PAVM
$9.11
-$0.22-2.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 420.00% | -99.50% | -99.39% | -99.21% | -99.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 420.00% | -99.50% | -99.39% | -99.21% | -99.05% |
| Cost of Revenue | 77.08% | -96.02% | -97.54% | -97.94% | -97.02% |
| Gross Profit | 13.16% | 87.01% | 94.91% | 96.19% | 93.24% |
| SG&A Expenses | 13.82% | -61.27% | -65.43% | -57.86% | -62.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -100.00% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.90% | -61.44% | -67.80% | -63.75% | -70.19% |
| Operating Income | -31.15% | 58.16% | 65.54% | 61.20% | 68.34% |
| Income Before Tax | -341.42% | -109.90% | 17.37% | 200.60% | 106.56% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -341.42% | -109.90% | 17.37% | 200.60% | 106.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 416.96% | -82.97% | -90.14% | -89.55% | -91.43% |
| Net Income | -188.26% | -108.36% | -10.10% | 224.69% | 110.20% |
| EBIT | -31.15% | 58.16% | 65.54% | 61.20% | 68.34% |
| EBITDA | -32.57% | 57.48% | 64.92% | 59.83% | 67.31% |
| EPS Basic | -87.84% | -104.57% | 38.25% | 148.66% | 106.27% |
| Normalized Basic EPS | 101.90% | 95.05% | 93.99% | 87.60% | 93.60% |
| EPS Diluted | -1,014.74% | -120.35% | 37.91% | 112.97% | 99.39% |
| Normalized Diluted EPS | 123.19% | 78.01% | 93.99% | 96.72% | 99.47% |
| Average Basic Shares Outstanding | 148.05% | 115.44% | 97.57% | 59.59% | 34.97% |
| Average Diluted Shares Outstanding | -79.63% | -51.53% | 97.57% | 503.83% | 1,543.79% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |